Alignment Healthcare, Inc. (NASDAQ:ALHC – Get Free Report) EVP Joseph Konowiecki sold 4,930 shares of the stock in a transaction on Tuesday, November 10th. The stock was sold at an average price of $7.20, for a total value of $35,496.00. Following the completion of the transaction, the executive vice president directly owned 1,075,375 shares in the company, valued at $7,742,700. This trade represents a 0.46% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
Alignment Healthcare Price Performance
Shares of Alignment Healthcare stock opened at $7.50 on Friday. Alignment Healthcare, Inc. has a twelve month low of $6.01 and a twelve month high of $25.12. The stock has a market capitalization of $1.57 billion, a P/E ratio of 57.70 and a beta of 1.07. The company has a current ratio of 1.71, a quick ratio of 1.71 and a debt-to-equity ratio of 1.17. The business’s fifty day moving average price is $8.79 and its 200 day moving average price is $16.14.
Alignment Healthcare (NASDAQ:ALHC – Get Free Report) last announced its quarterly earnings results on Thursday, October 29th. The company reported ($0.04) EPS for the quarter, hitting the consensus estimate of ($0.04). The company had revenue of $1.36 billion during the quarter, compared to analyst estimates of $1.31 billion. Alignment Healthcare had a return on equity of 12.46% and a net margin of 0.59%. The firm’s revenue was up 36.7% on a year-over-year basis. During the same period in the prior year, the firm posted $0.02 earnings per share. As a group, research analysts anticipate that Alignment Healthcare, Inc. will post -0.03 earnings per share for the current year.
Hedge Funds Weigh In On Alignment Healthcare
Hedge funds and other institutional investors have recently bought and sold shares of the stock. Gabelli Funds LLC boosted its holdings in Alignment Healthcare by 100.0% in the 3rd quarter. Gabelli Funds LLC now owns 50,000 shares of the company’s stock worth $408,000 after acquiring an additional 25,000 shares during the period. AlphaGrep UK Ltd purchased a new stake in shares of Alignment Healthcare during the third quarter valued at approximately $129,000. Benjamin Edwards Inc. raised its stake in shares of Alignment Healthcare by 2.7% during the third quarter. Benjamin Edwards Inc. now owns 51,551 shares of the company’s stock valued at $421,000 after purchasing an additional 1,351 shares during the period. Public Sector Pension Investment Board raised its stake in shares of Alignment Healthcare by 80.7% during the third quarter. Public Sector Pension Investment Board now owns 1,026,646 shares of the company’s stock valued at $8,475,000 after purchasing an additional 458,435 shares during the period. Finally, Edgestream Partners L.P. acquired a new position in shares of Alignment Healthcare during the third quarter worth $381,000. 86.19% of the stock is owned by institutional investors and hedge funds.
Analysts Set New Price Targets
ALHC has been the subject of a number of research analyst reports. The Goldman Sachs Group reissued a “buy” rating and set a $12.00 target price on shares of Alignment Healthcare in a research report on Thursday, October 22nd. Needham & Company LLC started coverage on shares of Alignment Healthcare in a research report on Wednesday, October 28th. They set a “hold” rating on the stock. JPMorgan Chase & Co. reduced their price target on shares of Alignment Healthcare from $10.00 to $8.00 and set an “overweight” rating on the stock in a research report on Friday, October 30th. TD Cowen decreased their price objective on shares of Alignment Healthcare from $12.00 to $10.00 and set a “buy” rating for the company in a research note on Monday, November 2nd. Finally, Scotiabank set a $9.00 price objective on shares of Alignment Healthcare in a research report on Friday, October 9th. Six analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $14.00.
Check Out Our Latest Research Report on Alignment Healthcare
Alignment Healthcare Company Profile
Alignment Healthcare, Inc. is a technology-enabled healthcare company focused primarily on serving older adults through Medicare Advantage plans. Its health plans, offered under the Alignment Health Plan name, combine insurance coverage with care coordination and support intended to address members’ medical and everyday health needs. The company uses a care model that includes personalized care teams, member support and technology to help coordinate services across providers. Its Medicare Advantage offerings include plan options such as HMO and PPO products, with availability and benefits varying by location.
Read More
- Five stocks we like better than Alignment Healthcare
- Checkmate for AI Chips? NVIDIA’s Crisis Opens the Board
- Can NVIDIA Maintain Its Momentum Without Huang?
- Six Flags Lost $366 Million in Q3—Its Insiders Just Went Shopping
- What Went Wrong With Amprius Technologies’ Q3? Less Than You’d Think
Receive News & Ratings for Alignment Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alignment Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
